The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells. [electronic resource]
Producer: 20091103Description: 37-47 p. digitalISSN:- 1872-8332
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Cycle
- Cell Hypoxia
- Cell Line, Tumor
- Cyclin-Dependent Kinases -- antagonists & inhibitors
- Humans
- Lung Neoplasms -- drug therapy
- Oxazoles -- therapeutic use
- Radiation Tolerance -- drug effects
- Thiazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.